Genomic reassortment of influenza A virus in North American swine, 1998-2011

NIH, Bethesda, MD, USA
Journal of General Virology (Impact Factor: 3.18). 09/2012; 93(Pt_12). DOI: 10.1099/vir.0.045930-0
Source: PubMed


Revealing the frequency and determinants of reassortment among RNA genome segments is fundamental to understanding basic aspects of the biology and evolution of the influenza virus. To estimate the extent of genomic reassortment in influenza viruses circulating in North American swine, we performed a phylogenetic analysis of 139 whole-genome viral sequences sampled during 1998-2011 and representing seven antigenically distinct viral lineages. The highest amounts of reassortment were detected between the H3 and the internal gene segments (PB2, PB1, PA, NP, M, and NS), while the lowest reassortment frequencies were observed among the H1γ, H1pdm, and NA segments, particularly N1. Less reassortment was observed among specific HA-NA combinations that were more prevalent in swine, suggesting that some genome constellations may be evolutionarily more stable.

Download full-text


Available from: Susan Elisabeth Detmer, Apr 08, 2015
17 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Influenza A viruses (IAV) are significant pathogens able to repeatedly switch hosts to infect multiple avian and mammalian species, including humans. The unpredictability of IAV evolution and interspecies movement creates continual public health challenges, such as the emergence of the 2009 pandemic H1N1 virus from swine, as well as pandemic threats from the ongoing H5N1 and the recent H7N9 epizootics. In the last decade there has been increased concern about the “dual use” nature of microbiology, and a set of guidelines covering “dual use research of concern” includes seven categories of potentially problematic scientific experiments. In this Perspective, we consider how in nature IAV continually undergo “dual use experiments” as a matter of evolution and selection, and we conclude that studying these properties of IAV is critical for mitigating and preventing future epidemics and pandemics.
    mBio 06/2013; 4(4). DOI:10.1128/mBio.00365-13 · 6.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vaccines provide a primary means to limit disease but may not be effective at blocking infection and pathogen transmission. The objective of the current study was to evaluate the efficacy of commercial inactivated swine influenza A virus (IAV) vaccines and experimental live-attenuated influenza virus (LAIV) vaccines against infection with H3N2 virus and subsequent indirect transmission to naïve pigs. The H3N2 virus evaluated was similar to the H3N2v detected in humans during 2011-12, which was associated with swine contact at agricultural fairs. One commercial vaccine provided partial protection measured by reduced nasal shedding, however, indirect contacts became infected, indicating the reduction in nasal shedding did not prevent aerosol transmission. One LAIV vaccine provided complete protection and none of the indirect contact pigs became infected. Clinical disease was not observed in any group, including non-vaccinated animals, a consistent observation in pigs infected with contemporary reassortant H3N2 swine viruses. Serum hemagglutination inhibition titers against the challenge virus were not predictive of efficacy: titers following vaccination with a LAIV that provided sterilizing immunity were below the level considered protective; yet titers in a commercial vaccine group that was not protected were above this same level. While vaccination with currently approved commercial inactivated products did not fully prevent transmission, certain vaccines may provide benefit for limiting shedding, transmission and zoonotic spillover of antigenically similar H3N2 viruses at agriculture fairs when administered appropriately and used in conjunction with additional control measures.
    Journal of Virology 07/2013; 87(17). DOI:10.1128/JVI.01038-13 · 4.44 Impact Factor
  • Source

    Israel Journal of Veterinary Medicine 01/2014; 69(2):62-67. · 0.35 Impact Factor
Show more